ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 104

Incidence Of Osteoporotic Hip Fractures In Estonia Between 2005 and 2012

Mikk Jürisson1,2, Anneli Uusküla1, Riina Kallikorm3, Sigrid Vorobjov2,4 and Margus Lember3, 1Department of Public Health, Faculty of Medicine, Tartu University, Tartu, Estonia, 2East Tallinn Central Hospital, Tallinn, Estonia, 3Department of Internal Medicine, Faculty of Medicine, Tartu University, Tartu, Estonia, 4National Institute for Health Development, Tallinn, Estonia

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Hip disorders and osteoporosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Epidemiology and Health Services I

Session Type: Abstract Submissions (ACR)

Background/Purpose: Monitoring the incidence of hip fractures is essential to measuring population health and the value of improvements in health care. Data on recent trends in hip fractures from Eastern European countries is limited.

Methods:

Ecologic trend study uses data from the public health insurance fund covering the whole country to estimate the incidence of hip fracture. For the incident hip fracture case definition was based on the ICD 10 diagnosis code S72.0 on the health care bill for a person who had not been treated for the same cause in a preceding 12 months.

Age-specific fracture rates were calculated for males and females in 10 year age brackets and for population aged over 40 years. Age-standardized incidence rates were estimated using direct standardization method with the European population set as standard; trend in the rates over time was assessed using linear regression.

Results:

In 2012, 833 patients were admitted for inpatient care for the incidence case of the hip fracture: 68% of the patients were women; the mean age was 76.7 years (SD 11.9; mean age for women 79.0 years, men 71.7 years; p-value<0.001).  The age-specific incidence rates among women ranged from 9/100 000 (age group of 40-49) to 654/100 000 (age group 80+ years). The age-specific incidence rates among men ranged from 16/100 000 (age group of 40-49) to 577/100 000 (age group 80+). 57% and 34% of hip fracture cases were attributed to the oldest age group (80+ years) among women and men accordingly.

Unlikely for women and other age groups among men, age-specific incidence rates for men over 80 years were increasing between 2005 and 2012.

Over the period of 2005-2012 the estimated age-standardized incidence rates ranged from 102/100 000 (95%CI 89−114; in 2005) to 81/100 000 (95%CI 70−91; in 2012) among women, and from 91/100 000 (95%CI 83−100; in 2005) to 74/ 100 000 (95%CI 67−81; in 2012) among men. For both genders, the age-standardized incidence rates decreased over the period of 2005-2012 (men: p= 0.022; women; p- 0.02).

Conclusion: To our knowledge this is the first population-based analysis of hip fracture incidence in Estonia. There was no statistical difference between age-standardized incidence rates among women and men. The incidence among men was comparable to that reported from men from other European countries. However, the incidence observed among Estonian women is lower than that reported from their European counterparts. There was a decline in age-standardized incidence over the study period among both genders.


Disclosure:

M. Jürisson,

ICUROS,

2;

A. Uusküla,
None;

R. Kallikorm,
None;

S. Vorobjov,
None;

M. Lember,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/incidence-of-osteoporotic-hip-fractures-in-estonia-between-2005-and-2012/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology